	Response to Gill et al., "Response to Factors associated with adherence to skin self-examination recommendations for melanoma patients: a prospective cohort study". J Am Acad Dermatol Nugent ST, Deitermann AM, Lin SK, Lewis DJ, Shin DB, Ming ME. PMID: 41360224 [PubMed - as supplied by publisher]
	MetaBlock-SE: A Method to Deal With Missing Metadata in Multimodal Skin Cancer Classification. IEEE J Biomed Health Inform Bouzon PHG, Rocha WFD, Souza LA, Pacheco AGC. PMID: 41359712 [PubMed - indexed for MEDLINE]
	Long-Pulsed Alexandrite Laser for Scrotal Angiokeratomas: Efficacy and Safety in a Clinical Study. J Cosmet Dermatol Molla A, Alraddadi M. PMID: 41358453 [PubMed - indexed for MEDLINE]
	Valosin containing protein (VCP/p97) expression in laryngeal squamous cell carcinoma: clinical evaluation and implications for targeted therapy. Pathol Oncol Res Seuthe IMC, Hunsicker-Biederbeck HC, Ruwe M, Knierer J, Ehrke-Schulz E, Erdogan E, Eichhorn S, Park JJ. PMID: 41357812 [PubMed - indexed for MEDLINE]
	Efficacy and safety of postoperative radiotherapy in locally advanced esophageal squamous cell carcinoma patients with pathologic incomplete response after neoadjuvant immunochemotherapy: a retrospective cohort study. Front Immunol Mu Y, Ding F, Qiao L, Wu X, Bao S, Liu F, Hu P, Zhang Y, Liang N, Xie J, Deng G, Hao Y, An D, Zhang J, Zhang J, Zhang Y. PMID: 41357221 [PubMed - indexed for MEDLINE]
	Efficacy of neoadjuvant pembrolizumab combined with paclitaxel and cisplatin in locally advanced oropharyngeal and hypopharyngeal squamous cell carcinoma: a retrospective study. Front Immunol Tang S, Lin G, Wu X, Chen Z. PMID: 41357220 [PubMed - indexed for MEDLINE]
	Anti-EGFR enhanced neoadjuvant immunotherapy versus neoadjuvant immunochemotherapy for locally advanced oral squamous cell carcinoma. Front Immunol Li P, Jin Q, Su M, Fang Q, Du W. PMID: 41357202 [PubMed - indexed for MEDLINE]
	The crossroads of inflammation and nutrition: predicting neoadjuvant immunochemotherapy efficacy in esophageal squamous cell carcinoma patients. Front Immunol Zhang G, Gong B, Guo Y, Lou J, Peng Y, Cai S, Fu Z, Xu Y, Yang L. PMID: 41357195 [PubMed - indexed for MEDLINE]
	Worse prognosis of local and locally advanced head and neck Merkel cell carcinoma: Is it time to change the treatment paradigm? Front Immunol Brenner R, Frumin Edri HT, Sarel I, Levko A, Turaieva S, Tairov T, Berezhnov I, Fenig S, Fenig E, Ziv-Baran T, Yakobson A, Shalata W. PMID: 41357189 [PubMed - indexed for MEDLINE]
	ChatGPT-4o as a diagnostic tool for skin cancer: Diagnostic accuracy in melanoma and non-melanoma detection. Cutan Ocul Toxicol Ünal E, Yücel MB, Gedikli SN, Akay BN. PMID: 41355746 [PubMed - as supplied by publisher]
	Genome-wide methylation profiles of primary and matched distant metastasis: insights from the Dutch Early-Stage melanoma (D-ESMEL) study. Hum Genomics Ouwerkerk J, Kerkour T, Mooyaart A, Zhou C, Boers R, Boers J, Gribnau J, Wakkee M, Li Y, Hollestein L. PMID: 41353171 [PubMed - as supplied by publisher]
	A 3D scanning system for measuring subcutaneous tumors in laboratory animals and expanded application to melanoma volume measurements. Med Eng Phys Zhang A, Zhu Y, Fu X, Liu B, Cui J, Wu Y, Wang Y, Zhang LW. PMID: 41352856 [PubMed - indexed for MEDLINE]
	Prognostic differences in melanoma between patients with locoregional disease at initial diagnosis and those who develop locoregional disease after progression during follow-up. Actas Dermosifiliogr Luna A, Alkhawaja A, Rizo D, Carrera C, Malvehy J, Puig S, Podlipnik S. PMID: 41352582 [PubMed - as supplied by publisher]
	Multi-Omics Analysis and Experimental Validation Identify RAD51 as a Key Biomarker in OSCC. IET Syst Biol Shi Y, Li X, Wang Y, Chen B, Bai G. PMID: 41350246 [PubMed - indexed for MEDLINE]
	Systematic analysis of non-melanoma skin cancer burden: A comparative study between China and the world from 1990 to 2021 and prediction to 2036. PLoS One Liang S, Sun T, Jia X, Cao J, Wang X. PMID: 41348680 [PubMed - indexed for MEDLINE]
	Treatment Outcomes of Surgery and ICI Therapy in 52 Patients With Esophageal Melanoma: A Retrospective Single-Center Cohort Study. J Dermatol Ishiguro A, Ogata D, Ishiyama K, Oguma J, Kurita D, Nakano E, Namikawa K, Takahashi A, Daiko H, Seto Y, Yamazaki N. PMID: 41347648 [PubMed - as supplied by publisher]
	Immune checkpoint inhibitors in melanoma: mechanisms, immune cell interactions, and the tumour microenvironment. Front Immunol Liang Y, Zheng Y, Zeng Y, Hu C, Si Y, Fan X, Chen Q. PMID: 41346595 [PubMed - indexed for MEDLINE]
	Clinical Effectiveness and Safety of Electrochemotherapy (ECT) in the Treatment of Locally Advanced Melanoma: A Systematic Review. Cureus Vickars DJ, Mandal A. PMID: 41346423 [PubMed]
	CD33 drives cutaneous melanoma: mendelian randomization confirms causality, multi-omics and in vitro experiments reveal M2 macrophage polarization-mediated progression. Int J Surg Hu L, Wang Y, Liu L, Liu X. PMID: 41346267 [PubMed - as supplied by publisher]
	Prognostic outcomes of immediate complete lymph node dissection versus observation in patients with acral melanoma of the sole with sentinel node metastasis: a retrospective, multicenter study. Int J Clin Oncol Inoue S, Koizumi S, Yamazaki N, Ichigozaki Y, Kitagawa H, Kiniwa Y, Sato S, Takai T, Doi R, Ito T, Yasuda M, Kuwatsuka Y, Maekawa T, Asai J, Miyagawa T, Matsushita S, Funakoshi T, Yamamoto Y, Inozume T, Kishi A, Takenouchi T, Kokubu H, Ito S, Umeda Y, Yamamoto Y, Ishizuki S, Iino S, Uchi H, Nakagawa T, Inafuku K, Haga T, Kaneko T, Nakagawa M, Kamiya H, Arima M, Hoashi T, Hiura A, Kanazawa N, Manabe K, Ishikawa M, Asagoe K, Iwasawa U, Kadono T, Hatta N, Minami S, Nakano E, Ogata D, Fukushima S, Uhara H, Nakama K, Komori T, Igawa K, Nakamura Y. PMID: 41345808 [PubMed - as supplied by publisher]

Articles 1 - 20 / 140285

Page 1 of 7015



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy